Latest News


Check back here regularly to find out what's going on locally within the Birmingham School and the wider speciality:



Period of Grace - Changes are coming! (Thu, 7 Mar 2019)

There is going to be a change regarding the period of grace after your CCT. This change is coming from HEEWM and you should be receiving information/guidance from HEEWM soon. The change will be from August 2019 so will affect trainees with a CCT date from August 2019...

>> Read more

Recent BJA Publications

COVID-19: a boost for intensive care authorship?
Editor – Almost 180 million cases of COVID-19 have been diagnosed, with almost 4.000.000 deaths1. Since this pandemic had unprecedented worldwide healthcare and socio-economic effects, the scientific world is under exceptional pressure regarding the need for knowledge on this new disease, including its pathophysiology and possible treatments. Such pressure prioritized scientific publications on COVID-19 over other medical conditions, with exponential increases in editorial workload2. Trials on COVID-19 underwent rapid ethical evaluation3; the peer-review process was shortened and was possibly less stringent4.
>> Read more

Safety and efficacy of tetrastarches in surgery and trauma: a systematic review and meta-analysis of randomised controlled trials
Hydroxyethyl starch (HES) 130 is a frequently used fluid to replace intravascular losses during surgery or trauma. In the past years, several trials performed in critically ill patients have raised questions regarding the safety of this product. Our aim in this meta-analysis was to evaluate the safety and efficacy of 6% HES during surgery and in trauma.
>> Read more

Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery. Comment on Br J Anaesth 2021; 127: 215–23
Editor—We read the article by Peng and colleagues1 with great interest. Their investigation assessed whether perioperative dexmedetomidine use is associated with improved survival after cardiac surgery. They concluded that perioperative dexmedetomidine infusion was associated with significantly reduced mortality from 30 days to 5 yr after surgery and improved 5 yr survival in patients undergoing cardiac surgery. To the best of our knowledge, this is the first study to demonstrate the long-term survival benefits of dexmedetomidine for patients undergoing cardiac surgery.
>> Read more

Selective mitochondrial antioxidant MitoTEMPO reduces renal dysfunction and systemic inflammation in experimental sepsis
Excess mitochondrial reactive oxygen species (mROS) in sepsis is associated with organ failure, in part by generating inflammation through the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome. We determined the impact of a mitochondrial-targeted antioxidant (MitoTEMPO) on mitochondrial dysfunction in renal proximal tubular epithelial cells, peritoneal immune cell function ex vivo, and organ dysfunction in a rat model of sepsis.
>> Read more

Adherence to the European Society of Cardiology/European Society of Anaesthesiology recommendations on preoperative cardiac testing and association with positive results and cardiac events: a cohort study
European Society of Cardiology/European Society of Anaesthesiology (ESC/ESA) guidelines inform cardiac workup before noncardiac surgery based on an algorithm. Our primary hypotheses were that there would be associations between (i) the groups stratified according to the algorithms and major adverse cardiac events (MACE), and (ii) over- and underuse of cardiac testing and MACE.
>> Read more

Print Print | Sitemap
Copyright BSA 2021